PTC Therapeutics Inc. logo

PTC Therapeutics Inc.

PTCT | NASDAQ
Chart Builder DCF Calculator
$65.26
-$0.11 (-0.17%)
At close: Sep 21, 2026, 4:00 PM ET
$65.49
+$0.23 (+0.35%)
Pre-market: Sep 22, 2026, 4:07 AM ET

Market Data

Market Cap
$5.46B
Enterprise Value
$3.91B
Beta
0.55
Average Volume
1.58M
Shares Outstanding (Diluted)
92.02M
Shares Change YoY
17.75%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US69366J2006

Price Performance

Price Change 1M
-6.4%
Price Change 3M
-20.5%
Price Change 6M
-2.2%
Price Change YTD
-15.0%
Price Change 1Y
7.3%
Price Change 3Y
172.8%
Price Change 5Y
66.1%
1M CAGR (ann.)
-7.7%
1Y CAGR (ann.)
7.8%
5Y CAGR (ann.)
9.4%
All-Time CAGR
10.9%

Valuation

PE Ratio
-112.52
Forward PE
21.76
PEG Ratio
0.88
Forward PEG
-1.17
PS Ratio
5.40
Forward PS
4.00
PB Ratio
-32.94
P/FCF Ratio
-72.98
P/Adj. FCF Ratio
-34.19
P/OCF Ratio
-176.38
EV/Sales
3.88
EV/EBIT
-31.10
EV/EBITDA
62.59
EV/FCF
-52.45
Earnings Yield
-0.9%
FCF Yield
-1.4%
Adj. FCF Yield
-2.9%

Financial Health

Net Cash
$1.53B
Total Debt
$696.47M
Cash & Short-Term Investments
$2.23B
Total Assets
$3.25B
Current Ratio
3.39
Quick Ratio
3.28
Debt / Equity Ratio
-4.21
Debt / EBITDA
11.14
Debt / FCF
-9.33
OCF / Debt
-0.04
Interest Coverage
0.63
Altman Z-Score
0.58
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
82.1%
Operating Profit Margin
11.5%
EBITDA Margin
17.2%
Net Profit Margin
-3.8%
FCF Margin
-7.4%
Adj. FCF Margin
-15.8%
SBC / Revenue
8.4%
SBC Impact (per share)
-113.4%

Returns

Return on Assets
-1.2%
Return on Equity
21.7%
Return on Invested Capital
2.6%
Return on Capital Employed
4.7%
Return on Tangible Assets
-1.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
7.2%
Revenue CAGR 5Y
16.4%
Revenue CAGR 10Y
33.3%
EPS CAGR 3Y
10743.8%
EPS CAGR 5Y
92.4%
EPS CAGR 10Y
10.4%
FCF CAGR 3Y
62.0%
FCF CAGR 5Y
212.4%
FCF CAGR 10Y
20.0%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
26
EPS Growth Next 3Y
357.8%
Revenue Growth Next 3Y
20.2%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
$0.29
EPS Growth Est (next Q)
45.9%
Revenue Est (next Q)
$303.94M
Revenue Growth Est (next Q)
44.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$105.13
Price Target Upside
61.1%

Cash Flow

Operating Cash Flow
$-30.5M
Free Cash Flow
$-74.63M
Adj. Free Cash Flow
$-159.28M
FCF Per Share
-$4.01
OCF Per Share
-$0.37
OCF/S Ratio
-3.0%

Income Statement

Revenue
$1.01B
Gross Profit
$476.39M
Operating Income
$116.26M
EBITDA
$62.53M
Net Income
$-38.38M
EPS (Diluted)
-$0.58
Revenue / Employee
$1.02M
Profit / Employee
$-38.73K
Employees
991

© 2026 bestshares.com. All rights reserved.